nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.14	1	CrCbGaD
Cyamemazine—HTR2C—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0263	0.0306	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0229	0.0266	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0225	0.0261	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0221	0.0257	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0213	0.0248	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0196	0.0228	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0192	0.0224	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0192	0.0223	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0189	0.0219	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0185	0.0215	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0182	0.0211	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0179	0.0208	CbGpPWpGaD
Cyamemazine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.0164	0.0191	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0156	0.0181	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0153	0.0178	CbGpPWpGaD
Cyamemazine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.0142	0.0166	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0142	0.0165	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.014	0.0162	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0138	0.0161	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0137	0.0159	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0134	0.0156	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0117	0.0136	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0115	0.0133	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0105	0.0122	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.0105	0.0122	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0103	0.012	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00823	0.00957	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00808	0.00939	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00672	0.00781	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00565	0.00656	CbGpPWpGaD
Cyamemazine—HTR2C—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00562	0.00653	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00555	0.00645	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00545	0.00633	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00545	0.00633	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00535	0.00622	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00525	0.0061	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00519	0.00603	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00519	0.00603	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00508	0.00591	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00502	0.00584	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0049	0.0057	CbGpPWpGaD
Cyamemazine—HTR2A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00488	0.00567	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00484	0.00562	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00484	0.00562	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00482	0.0056	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00481	0.00559	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00472	0.00549	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00464	0.00539	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00456	0.0053	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0045	0.00523	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00447	0.0052	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00441	0.00513	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00436	0.00507	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00435	0.00506	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00434	0.00505	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00433	0.00504	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00423	0.00492	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0042	0.00488	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0042	0.00488	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00412	0.00479	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00412	0.00479	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00412	0.00479	CbGpPWpGaD
Cyamemazine—HTR2C—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00395	0.00459	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0039	0.00454	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00383	0.00446	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00378	0.0044	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00377	0.00438	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00372	0.00432	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00371	0.00432	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0037	0.0043	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00368	0.00428	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00368	0.00428	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00358	0.00416	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00353	0.00411	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00353	0.0041	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00351	0.00408	CbGpPWpGaD
Cyamemazine—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00343	0.00399	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00342	0.00398	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00332	0.00385	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00323	0.00375	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0032	0.00372	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0032	0.00372	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00317	0.00369	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00314	0.00365	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00314	0.00365	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00307	0.00357	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00306	0.00356	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00301	0.0035	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00297	0.00346	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00292	0.00339	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00288	0.00335	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00283	0.00329	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00283	0.00329	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00281	0.00326	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0028	0.00326	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00269	0.00312	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00262	0.00304	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00246	0.00286	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00245	0.00285	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00241	0.00281	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00233	0.00271	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00229	0.00266	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00227	0.00264	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00223	0.00259	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00213	0.00248	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00208	0.00242	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00208	0.00242	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00199	0.00232	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00194	0.00225	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00192	0.00224	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00189	0.0022	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00189	0.0022	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00187	0.00218	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00181	0.0021	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00181	0.0021	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.0018	0.00209	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00177	0.00206	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00177	0.00206	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00177	0.00205	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00176	0.00204	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00173	0.00201	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0017	0.00198	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0017	0.00198	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00168	0.00196	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00168	0.00195	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00165	0.00192	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00164	0.00191	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00164	0.00191	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00163	0.00189	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00161	0.00187	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00161	0.00187	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0016	0.00186	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.0016	0.00186	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00153	0.00177	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00152	0.00176	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.0015	0.00174	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00148	0.00172	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00146	0.0017	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00145	0.00169	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00145	0.00169	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00139	0.00162	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00138	0.0016	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00136	0.00159	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00132	0.00153	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00129	0.0015	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00126	0.00147	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00126	0.00146	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00124	0.00144	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.0012	0.00139	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00118	0.00137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00118	0.00137	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00113	0.00131	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00112	0.0013	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00112	0.0013	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00109	0.00127	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00107	0.00125	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00107	0.00124	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00104	0.00121	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00102	0.00119	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00102	0.00119	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00101	0.00117	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00101	0.00117	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000978	0.00114	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00097	0.00113	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00097	0.00113	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00096	0.00112	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000952	0.00111	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000952	0.00111	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00093	0.00108	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000913	0.00106	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000901	0.00105	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000888	0.00103	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000885	0.00103	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000873	0.00101	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000872	0.00101	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000859	0.000998	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000857	0.000996	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000815	0.000947	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000746	0.000867	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000732	0.000851	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00071	0.000825	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000707	0.000822	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.0007	0.000814	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000695	0.000807	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000632	0.000735	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000616	0.000716	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000608	0.000706	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000605	0.000703	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000604	0.000702	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000597	0.000694	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000549	0.000638	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000539	0.000627	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000525	0.00061	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000515	0.000599	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000487	0.000566	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000423	0.000491	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000419	0.000487	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000415	0.000482	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000364	0.000423	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000358	0.000416	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000288	0.000334	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00025	0.00029	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000245	0.000285	CbGpPWpGaD
